Myelodysplastic Syndromes (MDS) are a group of hematologic disorders characterized by ineffective hematopoiesis, leading to blood cytopenias, dysplastic changes in bone marrow cells, and an increased risk of progression to acute myeloid leukemia (AML). These syndromes predominantly affect older adults and result from clonal abnormalities in hematopoietic stem cells.